Cargando…

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Matthews, LH McCormick, Noble, F, Tod, J, Jaynes, E, Harris, S, Primrose, J N, Ottensmeier, C, Thomas, G J, Underwood, T J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702008/ https://www.ncbi.nlm.nih.gov/pubmed/26695557 http://dx.doi.org/10.1038/bjc.2015.460

Ejemplares similares

Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma
por: McCormick Matthews, L H, et al.
Publicado: (2015)

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
por: Noble, Fergus, et al.
Publicado: (2016)

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
por: Neale, R E, et al.
Publicado: (2009)

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
por: Bain, G H, et al.
Publicado: (2015)

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
por: Feilchenfeldt, J, et al.
Publicado: (2015)

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
por: Maréchal, R, et al.
Publicado: (2010)

Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma
por: Underwood, Timothy J, et al.
Publicado: (2015)

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
por: Curtis, Nathan J, et al.
Publicado: (2014)

Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
por: Garcia, Edwin, et al.
Publicado: (2016)

Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma
por: Manousopoulou, Antigoni, et al.
Publicado: (2018)

Corrigendum to “Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively”
por: Yu, Qi, et al.
Publicado: (2018)

Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India
por: Dar, N A, et al.
Publicado: (2013)

Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma
por: Pickering, Oliver J., et al.
Publicado: (2021)

Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
por: Garcia, Edwin, et al.
Publicado: (2019)

ctDNA as a biomarker of progression in oesophageal adenocarcinoma
por: Bonazzi, V.F., et al.
Publicado: (2022)

BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
por: Yu, Jing, et al.
Publicado: (2022)

Corrigendum to: Antemortem diagnosis of nonbacterial thrombotic endocarditis in a patient with previously resected pancreatic adenocarcinoma: a case report
Publicado: (2020)

Fibroblasts derived from oesophageal adenocarcinoma differ in DNA methylation profile from normal oesophageal fibroblasts
por: Smith, Eric, et al.
Publicado: (2017)

Corrigendum: Risks, precipitants and clinical presentation of gastro-oesophageal reflux disease at the Kilimanjaro Christian Medical Centre in Tanzania
por: Mwandri, Michael Bartholomew, et al.
Publicado: (2015)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection
por: Saso, Kazuhiro, et al.
Publicado: (2019)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Corrigendum to “Considerations for the Treatment of Oesophageal Cancer with Radiotherapy During the COVID-19 Pandemic” [Clin Oncol 32 (2020) 354–357]
por: Jones, C.M., et al.
Publicado: (2021)

Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers [Corrigendum]
Publicado: (2023)

The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2019)

Plasma-derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells
por: Yang, Lifei, et al.
Publicado: (2022)

miR-146a-5p mediates epithelial–mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2
por: Wang, Cong, et al.
Publicado: (2018)

Impact of incremental circumferential resection margin distance on overall survival and recurrence in oesophageal adenocarcinoma
por: Knight, W. R. C., et al.
Publicado: (2018)

Proposed follow up programme after curative resection for lower third oesophageal cancer
por: Moyes, LH, et al.
Publicado: (2010)

Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”
por: Zuo, Didi, et al.
Publicado: (2020)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma
por: Ye, Song, et al.
Publicado: (2022)

Tonsillar metastasis of oesophageal adenocarcinoma
por: Struijs, Bram, et al.
Publicado: (2007)

Corrigendum. Septum resection in women with a septate uterus: a cohort study
por: Rikken, J F W, et al.
Publicado: (2020)

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
por: Smith, R A, et al.
Publicado: (2011)

Corrigendum to “Serglycin‐induced interleukin‐1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts topromote tumour angiogenesis and growth”
Publicado: (2023)

GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
por: Ouyang, Fei, et al.
Publicado: (2021)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_us9f8knb677hnq60b6g2paov2l